Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss-Reference-Cited by-同舟云学术

Dose Frequency Optimization of the Dual Amylin and Calcitonin Receptor Agonist KBP-088: Long-Lasting Improvement in Food Preference and Body Weight Loss

Published:2020-02-18 Issue:2 Volume:373 Page:269-278
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Larsen Anna Thorsø^ORCID,Sonne Nina,Andreassen Kim V.,Karsdal Morten A.,Henriksen Kim

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference66 articles.

1. Calcitonin and omega-3 fatty acids exhibit antagonistic and non-additive effects in experimental diabetes;Adeyemi;Pathophysiology,2018

2. A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats

3. Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias

4. Progressive Reduction in Body Weight after Treatment with the Amylin Analog Pramlintide in Obese Subjects: A Phase 2, Randomized, Placebo-Controlled, Dose-Escalation Study

5. Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss;Biomedicine & Pharmacotherapy;2023-08

2. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins;Pharmacological Reviews;2022-12-08

3. Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models;Biomedicine & Pharmacotherapy;2022-12

4. The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy;Biomedicines;2022-09-22

5. A structural basis for amylin receptor phenotype;Science;2022-03-25